In the field of cell and tissue engineering, culture expansion of human cells in monolayer plays an important part. Traditionally, cell cultures have been supplemented with serum to support attachment and proliferation, but serum is a potential source of foreign protein contamination and viral protein transmission. In this study, we evaluated the use of human serum for experimental human articular chondrocyte expansion and to develop a method for preparation of large volumes of high-quality human serum from healthy blood donors. Human autologous serum contained high levels of epidermal-derived growth factor and platelet-derived growth factor-AB and supported proliferation up to 7 times higher than FCS in primary chondrocyte cultures. By letting the coagulation take place in a commercially available transfusion bag overnight, up to 250 ml of growth factor-rich human serum could be obtained from one donor. The allogenic human serum supported high proliferation rate without loosing expression of cartilage-specific genes. The expanded chondrocytes were able to redifferentiate and form cartilage matrix in comparable amounts to autologous serums. In conclusion, the transfusion bags allow preparation of large volumes of growth factor-rich human serum with the capacity to support in vitro cell expansion. The data further indicate that by controlling the coagulation process there are possibilities of optimizing the release of growth factors for other emerging cell therapies.
INTRODUCTION
tor-β (TGF-β), another factor found in its highest content in platelets (1) , has been shown to have effect on both the proliferation and matrix-forming ability of ar-In the growing fields of tissue engineering and clinical cell therapy, which have the potential to treat many ticular chondrocytes [reviewed by Grimaud et al. (13) ]. Other factors found in serum that have been shown to disorders in the human body, the use of autologous cells and serum is fundamental for minimizing the risks for stimulate the proliferation of cells of mesodermal origin (6) and negatively regulate the chondrogenesis of mes-infection and immunological rejection. Serum, the clear liquid part of the blood that remains after blood cells enchymal stem cells (34) are, respectively, basic fibroblast growth factor (bFGF) and epidermal growth factor and clotting proteins have been removed, is used as a multifunctional supplement in the cultures. The serum is (EGF). It is well known that articular chondrocytes tempo-supplementing the culture medium with buffer capacity, transportation proteins, antioxidants, cytokines, and at-rary loose their chondrogenic phenotype during expansion in monolayer and that the cells are able to reexpress tachment and growth factors. Some of the growth factors important for the proliferation of eukaryotic cells are re-typical cartilage matrix proteins when placed in a 3D environment (3) . This redifferentiation potential has been leased from granules in platelets by the activation of the coagulation process during the preparation of the serum used for formation of ex vivo engineered cartilage grafts for potential treatment of large articular lesions and os- (16, 27) . One factor that was discovered as a major mitogenic factor in serum that is absent from plasma is plate-teoarthritis (10) (11) (12) .
Recently it has been shown that the proliferation and let-derived growth factor (PDGF) (2) . PDGF has been shown to regulate proliferation and matrix formation of redifferentiation ability is affected by the addition of specific growth factors (17,23) and the choice of serum chondrocytes in vitro (4, 14) . Transforming growth fac-470 TALLHEDEN ET AL. batch (7, 33) . Additionally, the species origin of serum lin and insulin-like growth factor 1 (IGF-1) was determined by radioimmunoassay (Insulin RIA; Kabi-Pharmacia, has been shown to be important for the initial attachment and proliferation of articular chondrocytes (7) , and an-Uppsala, Sweden and IGF-1 RIA by extraction; Nichols Inst. Diagnostics, San Juan Capistrano, CA, USA). Cor-other study has indicated that optimal conditions for culturing mammalian chondrocytes must be determined for tisol was analyzed by an enzyme immunochemical (EIA) method (Immulite cortisol kit; Diagnostic Product each species individually (32).
In cultures with human cancellous bone cells, serum Corporation, DPC Scandinavia). bFGF, EGF, TGF-β1, and PDGF-AB were analyzed by ELISA technique ac-of human origin has been reported to be superior for monolayer expansion and redifferentiation (15,24), and cording to the manufacturer's recommendations (R&D Systems). in our lab we have used autologous human serum for clinical cell culture since 1987 (5) . For all of the 1750
Cell Culture autologous procedures processed to date, 100 ml of whole blood corresponding to 40 ml of serum has been Surplus articular cartilage was collected from patients (age 18-33) undergoing patellar groove reconstruction collected from all patients. In this study our aim was to compare FCS with human serum for the supplementa-surgery or anterior cruciate ligament reconstruction as described previously (30). Isolated chondrocytes were tion of human articular chondrocyte culture and to develop a method for preparation of large volumes of high-cultured in DMEM/F12 (Invitrogen, Grand Island, NY) supplemented with L-ascorbic acid (0.025 mg/ml; Apo-quality human serum from healthy blood donors.
tekets produktionsenhet Umeå, Sweden), gentamicin MATERIALS AND METHODS sulphate (50 mg/l; Gibco, Scotland), amphotericin B Serum (250 µg/ml; Gibco), L-glutamine (2 mM; Gibco) (culture medium), and with different serum as described below Autologuos human serum (aHS) was prepared acin the proliferation assays. Generally, the first medium cording to the standard method for autologous chonchange was made at day 6 and thereafter twice a week. drocyte transplantation (ACT). Briefly, the serum was Subculture was made with trypsin-EDTA solution collected in tubes containing clot activation factor (Ven-[0.125% trypsin (Invitrogen) diluted in 0.1 M phosoject II Autosep gel + clot ACT) from patients donating phate-buffered saline (PBS) with 0.2 g/L EDTA] when cartilage. After 30 min of coagulation at room temperathe cells reached 80% confluence. ture, the tubes were centrifuged at 1000 × g for 5 min. Five different batches of fetal calf serum (FCS) were Proliferation Assay 1 purchased from three different suppliers: two from PAA Isolated chondrocytes were seeded at 4-12 × 10 3 Laboratories GMBH (Linz, Austria), two from Bio cells/cm 2 (dependent on the available amount of cells) Whittaker (Verviers, Belgium), and one from Biotech in 25-cm 2 Costar culture flasks (Costar, Corning Incor-Line (Slangesrup, Denmark). porated, Corning, NY, USA) in culture medium supple-Human serum (ϳ450 ml) was collected from blood mented with either 10% aHS or FCS. All flasks were donors (blood group B) attending to their regular donaharvested when the first flask reached 80% of conflution. Half of the volume from each donor was collected ence. The results were analyzed by microscopic obserin sterile glass bottles and the other half in transfusion vations and cell counting in a hematocytometer. bags (dry pack, JMS, Singapore). The serum in the glass bottles (gHS) and in the transfusion bags (tHS) was Proliferation Assay 2 blended by turning the containers upside down three Cells isolated from biopsies were seeded in triplicates times, left in room temperature for 1 h, and stored overat 10 × 10 3 cells/cm 2 in 12-well plates (Costar) for pronight at 4-8°C before centrifugation at 1000 × g for 5 liferation analysis or culture bottles for expansion with min. The serum batches from the different donors were culture medium supplemented with 10% of either aHS, pooled, sterile filtered, aliquoted, and frozen at −20°C tHS, gHS, or cHS serum. Separate plates were harvested until use. Commercial human serums (cHS) were purat days 6 and 12 by rinsing with phosphate buffer and chased from two different suppliers (PelFreeze, lot No. then frozen at −20°C until DNA analysis was made as 3110 and PAA, lot No. B03121-502).
described below for the pellets. The bottles were ex-Serum Component Analysis panded for one passage until RNA isolation and matrix production capacity test was performed. The fatty acid profile in the serum batches were determined after lipid extraction, isolation of phosphatidyl-Isolation of Total RNA choline, alkaline transmethylation, and analysis of the formed fatty acid methyl esters by capillary gas chroma-Total RNA was isolated from 1 × 10 6 cells cultured in monolayer (passage 1) with supplementation of aHS, tography as previously described in detail (20,26). Insu-gHS, and tHS serum by using an RNeasy mini kit (Qia-with 0.5 ml of defined medium, consisting of DMEM-HG (PAA Laboratories, Linz, Austria) supplemented gen, Hilden, Germany) according to the manufacturer's description. Contaminating genomic DNA was removed with ITS-G (Life Technologies, Sweden), 5.0 µg/ml linoleic acid (Sigma-Aldrich, Stockholm), 1.0 mg/ml hu-from the isolated RNA by using a DNA-free kit (Ambion, Huntingdon, UK) and total RNA content was then man serum albumin (HAS) (Equitech-Bio, TX, USA), 10 ng/ml TGF-β1 (R&D Systems, UK), 10 −7 M dexa-quantified by spectrophotometry. methasone (Sigma), 14 µg/ml ascorbic acid (Sigma), Real-Time Quantitative PCR and 1× penicillin-streptomycin (PAA Laboratories). The Expression patterns of four cartilage genes were cells were centrifuged at 500 × g for 5 min and mainanalyzed by real-time PCR using an ABI PRISM 7000 tained at 37°C in 7% CO 2 /93% air. The medium was (Applied Biosystems, Foster City, CA, USA) sequence changed twice a week. detector and software system. TaqMan MGB probes Histology of Pellets. On day 7 and 14 the pellets (FAM dye labeled) and primers for type I collagen were fixed in Histofix TM (Histolab Products AB, Swe-(Hs00164004_m1), type IIa collagen (Hs00156568_m1), den), dehydrated, and embedded in paraffin. Sections (5 type IIb collagen (Hs01064869_m1), and type X collaµm) were cut and placed onto microscope slides (Supergen (Hs00166657_m1) were ordered from Applied Biofrost Plus, Menzel-Gläser, Germany), deparaffinized, systems assays-on-demand (20× assay mixes). All genes and stained with Safranin-O or immunoassayed with were designed to amplify fragments of 70-150 base anti-type I and II collagen, as described below. The pairs, and 18S rRNA labeled with VIC/TAMRA was stained sections were analyzed by a Nikon Optiphot2used as endogenous control (Applied Biosystems).
pol microscope (Nikon Instruments Inc., Melville, NY, In vitro reverse transcription was performed with 500 USA) and digital pictures were taken with a ACT-1 softng total RNA using random hexamer primers and Taqware (Nikon). man Reverse Transcription reagents (Applied Biosys-Immunohistochemistry of Pellets. Deparaffinized sectems). Real-time PCR was performed with 5 µl of ditions were digested with hyaluronidase, 8000 U/ml luted cDNA (1:10) corresponding to 10 ng RNA, 15 µl (Sigma) in 0.1 M PBS for 60 min at 37°C and blocked of TaqMan Universal PCR master mixture (Applied with 3% bovine serum albumin (BSA; Sigma) in PBS Biosystems), 1× assay-on-demand mixes of primers and for 5 min. The primary monoclonal antibodies (anti-TaqMan MGB probes. All samples were analyzed in collagen type I and II (ICN Biomedicals, Aurora, OH, triplicate and PCR was performed in optical 96-well mi-USA)) were diluted 1:150 in PBS containing 3% BSA crotiter plates (Applied Biosystems). After an initial deand incubated with the sections for 1 h at room temperanaturation step at 95°C for 10 min, the cDNA products ture. The secondary antibody, peroxidase-conjugated were amplified with 40 PCR cycles, consisting of a degoat anti-mouse (1:150) (Jackson Immunoresearch Labnaturation step at 95°C for 15 s and an extension step at oratories, PA, USA) was applied to the sections for 1 h 60°C for 1 min.
at room temperature. A substrate kit (Vector VIP; Vec-To analyze the real-time PCR data a standard curve tor Laboratories, Burlingame, CA, USA) was used for method was used. The data were analyzed using ABI visualization and Fast Green (Sigma) for counter-Prism 7000 SDS software (Applied Biosystems). For staining. each sample, the C t sample values were determined as the cycle number at which all samples were in the exponen-Biochemical Analysis of Pellets. On days 7 and 14, tial phase of amplification. By using the formulas below, pellets were digested with papain (Sigma) solution [0.3 a value (Y) was obtained as a measure of the gene exmg papain/ml sodium phosphate buffer (20 mM) with 1 pression correlated to the standard curve for that par-mM EDTA and 2 mM dithiothreitol] for 60 min at 60°C. ticular gene: X = (C t sample − intercept value)/slope value;
The digested pellets were then mechanically dissolved X 10 = Y. The Y value for each cDNA sample and target by vortex and further analyzed for DNA, GAG, and hysequence was divided by the Y value from the housedroxyproline content. keeping gene (18S) for that particular sample to derive The amount of DNA was measured with CyQuant a ∆C t value (PE-ABI; Sequence Detector User Bulletin 2).
cell proliferation assay kit (Molecular Probes, Eugene, OR, USA), according to the manufacturer's instructions.
Redifferentiation Potential Assay
The GAG content was measured spectrophotometrically at 515 nm using dimethylmethylene blue assay (9), Pellet Culture. The matrix production capacity of the expanded chondrocytes was analyzed in a 3D pellet cul-with chondroitin sulphate as a calibrator, and normalized to the DNA amount in the pellet. ture system as described previously (18, 23) . Briefly, 2.0 × 10 5 cells from passage 1 (maximum 7 cell dou-Hydroxyproline, as a measurement of total collagen in the digested pellet, was analyzed with a modified blings) were placed into polypropylene conical tubes method, described previously (25). Briefly, digested pel-Large Batch Production of Human Serum lets were hydrolyzed overnight with 6 N hydrochloric
To establish a method for production of large volacid at 127°C and then dissolved in assay buffer [3:2:10 umes of human serum, serum was collected in transfuof n-propanol/deionized water/stock buffer (0.24 M citsion bags (tHS) and glass bottles (gHS) from healthy ric acid, 0.88 M sodium acetate trihydrate, 0.88 M anhyblood donors. These serums were left overnight for codrous sodium acetate, 0.21 M acetic acid, and 0.85 M agulation and then compared to serum collected accordsodium hydroxide), pH 6.1]. To the dissolved samples ing to the standard protocol for preparing autologous chloramine-T reagent [0.282 g chloramine-T (Sigma), 1 serums for ACT (coagulation for 30 min before centrifuml deionized water, 1 ml n-propanol, and 8 ml stock gation). The amount of serum obtained from one donor buffer] and DMBA reagent [2 g dimethylaminobenzal-(450 ml blood) ranged between 150 and 250 ml. dehyde (Sigma), 1.25 ml n-propanol, and 2.75 ml per-
The growth factor analysis showed that the serum chloric acid] was added. Hydroxyproline content was prepared according to the standard method contained measured spectrophotometrically at 550 nm with refersignificantly (p < 0.05) lower amounts of EGF and FGF ence at 650 nm and normalized to the DNA content in than the tHS and gHS serum batches (Fig. 2) . The tHS the pellet. As a calibrator, hydroxyproline (Sigma) was serum contained the highest concentration of FGF and used and all analysis was made in duplicate from duplithe gHS serum had the highest concentration of EGF. cate pellets.
Although a large individual difference was observed in the amounts of EGF, the control tube, which was left Statistics overnight before centrifugation, also contained increased For statistical analysis Student' t-test (two-sided, un-(not significant) amounts of FGF and EGF in comparirelated two sample equal variance) was used. Values of son to the standard tube method. No difference was obp < 0.05 were considered to represent a significant difserved between the batches in amounts of TGF-β and ference. All experiments were repeated with at least PDGF-AB. three different donors of serum and/or cells unless otherwise stated. Data are presented as mean values corre-Growth Factor Profiles lated to autologous serum (standard tube, 30-min coagu-
The large volume batches obtained from blood dolation) with ±1 SD. The standard error in autologous nors (tHS and gHS) were then extensively compared to serum represents percentage of standard deviation com-aHS serums and to commercially available human serum pared to mean of the different donors.
batches (cHS). The growth factor profiles of the different serums did not differ remarkably with the exception RESULTS of the Pelfreeze produced batch, which differed signifi-aHS Versus FCS cantly in four of the assays ( Table 2 ). The batch from In the initial analysis of chondrocytes cultured in me-PAA contained lower amounts of PDGF. The autolodia supplemented with aHS and FCS, respectively, a difgous serums contained on average four times lower ference was observed in morphology and proliferation amounts of FGF and EGF in comparison to the tHS and rate. Chondrocytes cultured in aHS appeared more gHS serum. "square like" and the proliferation rate was on average eight times higher (Fig. 1A) in comparison to FCS. Cells Proliferation cultured in FCS were thin and elongated (i.e., "fibroblast To test the functional effects of the observed differlike" (Fig. 1B.) . The difference between the aHS and ences between the human serums, proliferation assays FCS was obtained in all five tested batches of FCS (data with primary chondrocyte cultures were performed. The not shown).
analysis showed that the differences from the growth The differences between the serums persisted in the factor analysis persisted in the proliferation assay ( Fig.  amount of growth factors and in the fatty acid profiles 3). The aHS, tHS, and gHS were significantly better ( Table 1 ). The analysis consisted of 10 selected aHS than the commercial serums tested (p < 0.05). The sebatches and four different batches of FCS from three rum from Pelfreeze did not support any cell attachment different suppliers. All aHS batches contained higher or proliferation, and in the PAA serum batch the cells concentrations of EGF and PDGF while the FCS batches did attach but the proliferation rate was much lower than had elevated concentrations of FGF. In the fatty acid the other human serums. profiles significant differences were seen in 9 of the 11 factors analyzed. Generally the human serum contained Gene Expression significantly higher amounts of n-6 polyunsaturated fatty acids while the FCS batches contained more n-3
To study the effect of the human serums in monolayer culture, chondrocytes expanded in culture for one (Table 1 ). passage were analyzed for common chondrocyte expres-This observation was confirmed in the quantitative analysis of the proteoglycans and collagens per cell basis sion markers with quantitative real-time PCR. In the expression of type I, IIa, and IIb collagen and fibroblast ( Fig. 6 ). No significant difference was observed between the cells expanded in the different serum batches. growth factor receptor 3 (FGFR3) genes, no difference could be observed between the aHS, tHS, and gHS se-DISCUSSION rums (Fig. 4) .
The use of commercially available transfusion bags Differentiation was shown to be an easy and reliable method for collection of functional human serum for articular chondrocyte After monolayer expansion in medium with different serum supplementations, the differentiation and matrix-culture. The collected serum supported high proliferation rate without losing expression of cartilage-specific forming ability was analyzed with a pellet assay. The initially centrifuged cells formed spherical pellets after genes, and the chondrocytes expanded in the prepared serum were shown to be able to redifferentiate and form 1 night in culture and started to accumulate matrix proteins. The accumulation of matrix proteins resulted in cartilage matrix in comparable amounts to autologous serums (31) . increase in pellet diameter throughout the culture period. Within the pellets, cartilage matrix proteins (e.g., proteo-
The field of hybridoma cell culture has for a long time been a strong market for commercial serums glycans and collagens) were detected from day 7 by histological staining with Safranin-O and antibodies raised (mainly of bovine origin). Consequently, the production of serum batches has been optimized for this purpose. against collagen type II. At the final day of culture (day 14), no consistent difference could be seen histologically For experimental cell culture laboratories, it has therefore been necessary to develop functional serum screens between the cells expanded in the different serums when compared to autologous batches (Fig. 5) .
to identify suitable serum batches for their purpose. shown in cultures with human mesothelial cells that bo- able to test the proliferation stimulatory ability of human serum on the chondrocytes due to the fact that the redif-
The results are given as mean values with 1 SD in parentheses. *Significant difference (p < 0.05, Student's t-test) between aHS and ferentiation assay needs to be performed in serum-free FCS. conditions and that addition of high proliferative human serum to culture medium results in inability of pellet formation (authors' unpublished data).
In clinical diagnosis, serum has traditionally been These serum screens still play an important role in many collected in glass tubes and the glass in these tubes does cell culture labs in the choice of serum batches from activate the coagulation system and create a strong different preparations of different animal origins (22). In blood clot. Today, plastics have replaced the glass and the present study we compared the properties of bovine the tubes contain a clot-activating factor to activate coand human serum. We observed a large difference beagulation. These plastic tubes are used for standard preptween the serums in fatty acid profile and polyunsatuaration of autologous serum for ACT. In the current rated fatty acids; especially n-3 acids have been shown study, we observed that when coagulation was left to to suppress the inflammatory reaction in articular chon- take place for a longer time independent of collection available human serums; nevertheless, both the batches we tested should, according to the suppliers, be prepared vessel, higher amounts of growth factors were obtained in comparison to the standard protocol. Minor differ-"off the clot" (personal communication). The serum from Pelfreeze was prepared in plastic bags from male ences were also observed between the plastic and glass containers. This indicates on a function on the release donors and left for coagulation for at least 0.5 h while the batch from PAA was left overnight. This difference of growth factors into serum dependent on the time for coagulation and the materials used in the collection con-in coagulation time could be the explanation for the differences between the commercial serum batches. Ac-tainer. This further means that there are possibilities of adopting the preparation protocols of autologous serum cording to the manufacturers, the serums should be suitable for cell culture, but this statement was not supported to meet the needs of different types of cell cultures.
In our analysis of commercially available human se-by our data. In additional to proliferation, it is important that a rums, we were only able to find a few suppliers and batches on the market. It is therefore inaccurate to claim chosen serum batch is supporting expansion of cells with high differentiation potential. During monolayer that we have made a full testing of all commercially expansion, it is possible that the culture condition favors in the same allogenic batch of tHS serum (data not shown). This indicates that the matrix production poten-certain cell subpopulations (19) or that the cells are too strongly driven towards dedifferentiation (17) and the tial is different between different donors and can be further studied in detail by the use of a standardized serum cells thereby loose the ability to redifferentiate. In the current study, we show that the human serum batches, batch known to result in large amounts of potent cells.
The system could also be used for testing drug candi-prepared by transfusion bags and glass bottles, supported high proliferation of articular chondrocytes with-dates and other factors affecting the redifferentiation process. out losing the expression of cartilage-specific genes or the ability to redifferentiate and produce cartilage-specific Preferable to the use of serum is the use of serumfree culture conditions, and several of the components matrix. The redifferentiation potential of these serum batches was as good as that of autologous serum, which that support cell proliferation are commercially available as recombinant proteins. However, the inclusion of de-has been used for culture of autologous chondrocytes for clinical repair of deep cartilage injuries since 1987 (5) .
fined recombinant factors instead of serum will dramatically increase the costs for the procedure, and of the few Even if the different serum preparation methods resulted in significant differences in growth factor concentra-tissue engineering products found on the market today, several already have problems with reimbursements. It tions, these concentrations could not be translated to a consistent difference between different donors with the is therefore likely to believe that emerging cell therapies, like cardiomyocyte transplantation for ischemic heart aHS and the tHS and gHS batches in proliferation and matrix-forming ability. One explanation to this is that failure, will use autologous cells and serums, both from an immunoreactive (29) and economical point of view. we observed a fivefold difference in proteoglycan synthesis capacity in cells from different donors expanded In this study we have shown that there are possibilities 
